Table 7.
Approved monoclonal antibodies subject to FDA warnings and precautions for cytopenias.
| Cytopenia | Thrombocytopenia | Neutropenia | Lymphocytopenia |
|---|---|---|---|
| Adalimumab | Abciximab | Bevacizumab | Catumaxomab |
| Alemtuzumab 1 | Ado-trastazumab emtansine |
Blinatumomab | |
| Certolizumab pegol | Belantamab mafodoton-blmf | Brentuximab vedotin | |
| Ibritumomab tiuxetan 1 | Daratumumab | Daratumumab | |
| Infliximab | Palivisumab | Fam-trastuzumab Deruxtecan-nxki |
|
| Ofatumumab | Sarilumab | Isatuximab-irfc | |
| Obinutuzumab | |||
| Sacituzumab govitecan-hziy 1 | |||
| Sarilumab | |||
| Satralizumab-mwge | |||
| Trastuzumab |
1 Subject to boxed warning.